RFA: In Vitro Disease Modeling — T1D-on-a-Chip Platforms
Supports in vitro disease modeling for type 1 diabetes using chip-based systems and translational experimental platforms.
Breakthrough T1D — formerly JDRF, rebranded June 2024 — issued this FY26 RFA titled "In Vitro Disease Modeling: Type 1 Diabetes-on-a-Chip Platforms" to solicit development of microfluidic organ-on-a-chip or microphysiological systems that replicate T1D-relevant biology in vitro. The scientific rationale is that conventional 2D cell culture and animal models fail to capture the complex multicellula…
Development of microfluidic organ-on-a-chip or microphysiological platforms that replicate type 1 diabetes pathophysiology in vitro to advance disease modeling and therapy development.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline